A detailed history of Tctc Holdings, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tctc Holdings, LLC holds 2,830 shares of LLY stock, worth $2.57 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,830
Previous 2,885 1.91%
Holding current value
$2.57 Million
Previous $2.24 Million 14.17%
% of portfolio
0.09%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $39,867 - $49,997
-55 Reduced 1.91%
2,830 $2.56 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $3,553 - $4,753
6 Added 0.21%
2,885 $2.24 Million
Q4 2023

Feb 08, 2024

SELL
$525.19 - $619.13 $96,109 - $113,300
-183 Reduced 5.98%
2,879 $1.68 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $2,608 - $3,595
-6 Reduced 0.2%
3,062 $1.64 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $84,491 - $99,231
272 Added 9.73%
3,068 $1.05 Million
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $1,185 - $1,351
-4 Reduced 0.14%
2,796 $905,000
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $46,233 - $57,457
197 Added 7.57%
2,800 $802,000
Q4 2021

Feb 09, 2022

SELL
$224.85 - $279.04 $674 - $837
-3 Reduced 0.12%
2,603 $719,000
Q3 2021

Nov 04, 2021

BUY
$221.6 - $272.71 $69,804 - $85,903
315 Added 13.75%
2,606 $602,000
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $8,666 - $11,209
-48 Reduced 2.05%
2,291 $526,000
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $8,216 - $10,636
-50 Reduced 2.09%
2,339 $437,000
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $23,810 - $29,470
-200 Reduced 7.72%
2,389 $331,000
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $26,730 - $33,107
250 Added 10.69%
2,589 $341,000
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $34,706 - $37,752
325 Added 16.14%
2,339 $262,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $15,885 - $17,796
150 Added 8.05%
2,014 $233,000
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $160,043 - $200,025
1,864 New
1,864 $200,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tctc Holdings, LLC Portfolio

Follow Tctc Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.